BSEResultResults1d ago
Tejnaksh Healthcare Ltd
Please find enclosed unaudited financial result for half year ended Sep 26
Tejnaksh Healthcare Ltd has submitted unaudited financial results for the quarter ended September 30, 2026, with no material misstatements found by the independent auditor.
BSEBoard MeetingResults1d ago
Tejnaksh Healthcare Ltd
In continuation of our Letter dated 8th November 2026 we wish to inform you that a meeting of
the Board of Directors of the Company was held on Thursday, 12th November 2026 at 3:00 p.m. and
has transacted the following: -1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30TH September 2026 and took note of Limited Review Report
thereon, in terms of Regulation 33 of SEBI (Listing Obligations ....
Tejnaksh Healthcare Ltd has announced its un-audited financial results for the quarter ended September 30, 2026, which have been approved by the Board of Directors. The results are in compliance with the recognition and measurement principles laid down in Indian Accounting Standard 34.
BSEBoard MeetingResults6d ago
Tejnaksh Healthcare Ltd
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday, 12th Nov, 2026 to transact the business as given below:
1. To Consider and approve ....
Tejnaksh Healthcare Ltd has informed BSE that a meeting of the Board of Directors will be held on 12th November 2026 to consider and approve Un-Audited Financial Results for the quarter ended 30th September 2026.
BSECompany Update▲ PositiveRegulatory2 Nov 2026
Tejnaksh Healthcare Ltd
Respected Sir/Madam,
Please find attached the letter for your reference and record
Thanks
Tejnaksh Healthcare Ltd's Managing Director, Dr. Ashish V. Rawandale-Patil, has been selected as a mentor for the Technology Innovation Program 2027 (ES-TIP 2027) of the Endourological Society, a globally recognized international organization in the field of urology.
BSECompany Update▲ PositiveProduct Launch24 Oct 2026
Tejnaksh Healthcare Ltd
Respected Madam/Sir,
Please find attached letter.
Thanks & Regards
Tejnaksh Healthcare Ltd has announced the publication of a scientific validation study of its Pflow™ uroflowmetry device in the Indian Journal of Urology, demonstrating its agreement with conventional uroflowmetry parameters and supporting its utility as a convenient and patient-friendly solution.
BSECompany Update24 Oct 2026
Tejnaksh Healthcare Ltd
Respected Sir/Madam,
Please refer attached 74(5) Certificate for your reference.
Thanks & Regards
Tejnaksh Healthcare Ltd has issued a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, which is a compliance certificate related to the company's shareholding pattern.
BSECompany UpdateMgmt Change1 Oct 2026
Tejnaksh Healthcare Limited
Tejnaksh Healthcare Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Tejnaksh Healthcare Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
Tejnaksh Healthcare Limited
Tejnaksh Healthcare Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Tejnaksh Healthcare Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
Tejnaksh Healthcare Limited
Tejnaksh Healthcare Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Tejnaksh Healthcare Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
Tejnaksh Healthcare Limited
Tejnaksh Healthcare Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Tejnaksh Healthcare Limited has informed BSE about the re-appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
Tejnaksh Healthcare Ltd
Respected Madam/Sir,
Please find attached Reappointment of Independent Director Suhas Thorat for the second term.
Tejnaksh Healthcare Ltd has announced the reappointment of Suhas Thorat as an Independent Director for a second term of 5 years, as approved by the company's 18th Annual General Meeting.
BSEAGM/EGMResults1 Oct 2026
Tejnaksh Healthcare Ltd
Respected Madam/Sir,
Please find attached Scrutinizer Report.
Tejnaksh Healthcare Ltd has announced the voting results of its 19th Annual General Meeting, where all four resolutions were passed with requisite majority. The resolutions included the adoption of audited financial statements, appointment of a director, re-appointment of an independent director, and approval of material related party transactions.
BSEAGM/EGM29 Sept 2026
Tejnaksh Healthcare Ltd
Please refer letter attached for AGM proceeding held on 29th September 2026
Tejnaksh Healthcare Ltd held its 19th Annual General Meeting on September 29, 2026, through video conferencing. The meeting was attended by the Chairman, Directors, Key Managerial Personnel, Statutory Auditors, and Secretarial Auditor. The Chairman presented the company's performance for FY 2025-26 and discussed business opportunities and external factors affecting the business. E-voting facility was provided to shareholders, and the Scrutinizer will issue a consolidated report on voting results.
BSEInsider Trading / SAST26 Sept 2026
Tejnaksh Healthcare Ltd
Respected Sir/Madam,
Please refer attached closure of trading window intimation.
Tejnaksh Healthcare Ltd has announced the closure of its trading window for directors, KMPs, designated employees, and connected persons from October 1, 2026, until 48 hours after the release of its Q2 FY2026-27 financial results.
BSEOthersResults4 Sept 2026
Tejnaksh Healthcare Ltd
Dear Sir / Madam
With reference to captioned subject find enclosed herewith Annual Report of the Company for the F.Y.
2025-26
Kindly take the same on your record.
Tejnaksh Healthcare Ltd has filed its Annual Report for the financial year 2025-26.
BSEAGM/EGM4 Sept 2026
Tejnaksh Healthcare Ltd
This to inform that the 19th Annual General meeting to be held on 29th September 2026. Notice is attached for your reference
Tejnaksh Healthcare Ltd has announced the 19th Annual General Meeting (AGM) to be held on 29th September 2026.
BSEResultResults13 Aug 2026
Tejnaksh Healthcare Ltd
Please find attached unaudited FS as of June 26
Tejnaksh Healthcare Ltd has submitted unaudited financial results for the quarter ended June 30, 2026, with the review report by Maheshwari & Co. indicating no material misstatement.
BSEBoard MeetingResults13 Aug 2026
Tejnaksh Healthcare Ltd
In continuation of our Letter dated 08th August, 2026 we wish to inform you that a meeting oft he
Board of Directors of the Company was held on Thursday, 13th August, 2026 at 03:00 pm ....
Tejnaksh Healthcare Ltd held a board meeting on August 13, 2026, where they considered and approved unaudited financial results for the quarter ended June 30, 2026. The board also reappointed Mr. Suhas Vasantrao Thorat as a non-executive independent director for a second term, subject to shareholder approval.
BSEBoard MeetingResults8 Aug 2026
Tejnaksh Healthcare Ltd
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve We hereby inform you that ....
Tejnaksh Healthcare Ltd has scheduled a board meeting on 13/08/2026 to consider and approve un-audited financial results for the quarter ended 30th June 2026, reappoint an independent director, and consider any other matters with the permission of the chair.